On March 19, 2019, I sat in the audience of the scientific sessions at the Annual Meeting of the Society for Clinical Vascular Surgery (SCVS). I was there with two of my trainees who were eagerly waiting to present their research.
BY BETH BALES
Expanding the Board provides for broader representation while the three-year term for the chair provides continuity, said Michel S. Makaroun, MD, whose term as chair ended June 20. The changes as a whole “position the SVS Foundation Board for further growth,” he said.
BY BRYAN KAY
The Stanford University, California, vascular chief had intended it to be constructed this way. As is custom, the at-that-point SVS president-elect had been charged with devising the coveted E. Stanley Crawford Critical Issues Forum.
BY BRYAN KAY
Joining other bodies of medical professionals, the two organizations highlighted the sacred oath taken by physicians to “save and extend the quality of life” of all people. They went on to state that as membership groups they abhorred “injustice and violence of any kind.”
BY BRYAN KAY
Delivering data demonstrating the composition of the SVS along age, gender and ethnic lines, he indicated work remained to be done to achieve a more diverse organization, telling the Vascular Annual Meeting (VAM) replacement that “we ought to be able to do better.”
BY BETH BALES AND BRYAN KAY
The results were announced during the second session of the SVS Annual Business Meeting Saturday, June 20, when Dalman officially became SVS president, succeeding Kim Hodgson, MD.